577 related articles for article (PubMed ID: 10752806)
1. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
Ververs TF; van Dijk A; Vinks SA; Blankestijn PJ; Savelkoul JF; Meulenbelt J; Boereboom FT
Crit Care Med; 2000 Oct; 28(10):3412-6. PubMed ID: 11057794
[TBL] [Abstract][Full Text] [Related]
3. Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.
Valtonen M; Tiula E; Backman JT; Neuvonen PJ
J Antimicrob Chemother; 2000 May; 45(5):701-4. PubMed ID: 10797097
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of meropenem administered with prolonged infusion time in patients receiving continuous veno-venous hemofiltration].
Bo SN; Li HL; Zhu X; Yao GQ; Hu YF; Zhai SD; Lu W; Wang SY; Xu YZ; He B
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Mar; 24(3):145-8. PubMed ID: 22401158
[TBL] [Abstract][Full Text] [Related]
6. Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltration.
Krueger WA; Neeser G; Schuster H; Schroeder TH; Hoffmann E; Heininger A; Dieterich HJ; Forst H; Unertl KE
Chemotherapy; 2003 Dec; 49(6):280-6. PubMed ID: 14671427
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.
Robatel C; Decosterd LA; Biollaz J; Eckert P; Schaller MD; Buclin T
J Clin Pharmacol; 2003 Dec; 43(12):1329-40. PubMed ID: 14615469
[TBL] [Abstract][Full Text] [Related]
8. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients.
Bellomo R; Tipping P; Boyce N
Crit Care Med; 1993 Apr; 21(4):522-6. PubMed ID: 8472571
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration.
Ikawa K; Morikawa N; Ikeda K; Suyama H
J Infect Chemother; 2008 Feb; 14(1):35-9. PubMed ID: 18297447
[TBL] [Abstract][Full Text] [Related]
11. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
Kielstein JT; Czock D; Schöpke T; Hafer C; Bode-Böger SM; Kuse E; Keller F; Fliser D
Crit Care Med; 2006 Jan; 34(1):51-6. PubMed ID: 16374156
[TBL] [Abstract][Full Text] [Related]
15. Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?
Varghese JM; Jarrett P; Wallis SC; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA
J Antimicrob Chemother; 2015 Feb; 70(2):528-33. PubMed ID: 25336163
[TBL] [Abstract][Full Text] [Related]
16. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
Muhl E; Martens T; Iven H; Rob P; Bruch HP
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
[TBL] [Abstract][Full Text] [Related]
17. Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration.
Bilgrami I; Roberts JA; Wallis SC; Thomas J; Davis J; Fowler S; Goldrick PB; Lipman J
Antimicrob Agents Chemother; 2010 Jul; 54(7):2974-8. PubMed ID: 20479205
[TBL] [Abstract][Full Text] [Related]
18. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE
Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
[TBL] [Abstract][Full Text] [Related]
19. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure.
Bellomo R; McGrath B; Boyce N
Crit Care Med; 1994 May; 22(5):833-7. PubMed ID: 8181293
[TBL] [Abstract][Full Text] [Related]
20. Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration.
Thalhammer F; Schenk P; Burgmann H; El Menyawi I; Hollenstein UM; Rosenkranz AR; Sunder-Plassmann G; Breyer S; Ratheiser K
Antimicrob Agents Chemother; 1998 Sep; 42(9):2417-20. PubMed ID: 9736573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
